Leave your feedback Share Copy URL https://ar-c.org/video/hH2pdxkYM85.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [y5hnqPhi0Wk] Health Updated on August 11, 2026 EDT — Published on August 11, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. ctir5Gq5DFP D1wx8CfT5TM NHezcSLKpiL WHBfUJQ5pcF 4myi2h7qFOz
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. ctir5Gq5DFP D1wx8CfT5TM NHezcSLKpiL WHBfUJQ5pcF 4myi2h7qFOz